Zug
Switzerland
64
2024-10-10
56
2025-05-20
These are the the leading inventors for applications assigned to Baxalta GmbH:
Baxalta GmbH based in Zug, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME
#2 | 2022-06-09THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME
#3 | 2021-09-23 ✅ Patent 12,303,463 granted on 2025-05-20Female-female adapter
#4 | 2021-05-06COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION
#5 | 2020-05-21 ✅ Patent 11,684,548 granted on 2023-06-27Pooling device for single or multiple medical containers
#6 | 2020-04-02 ✅ Patent 11,185,575 granted on 2021-11-30Subcutaneous administration of ADAMTS13
#7 | 2020-01-16METHODS FOR DETERMINING POTENCY OF ADENO-ASSOCIATED VIRUS PREPARATIONS
#8 | 2020-01-16 ✅ Patent 11,090,583 granted on 2021-08-17Bottom section for being connected to an assembly with plate settler, and assembly with plate settler
#9 | 2019-12-05 ✅ Patent 11,000,561 granted on 2021-05-11Adeno-associated virus purification methods
#10 | 2019-11-07 ✅ Patent 11,191,818 granted on 2021-12-07Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome
#11 | 2019-10-24 ✅ Patent 11,957,867 granted on 2024-04-16Syringe stabilizer
#12 | 2019-09-05 ✅ Patent 11,921,117 granted on 2024-03-05Characterization of subvisible particles using a particle analyzer
#13 | 2019-08-22 ✅ Patent 11,583,563 granted on 2023-02-21Adeno-associated virus formulations
#14 | 2019-08-15 ✅ Patent 10,758,599 granted on 2020-09-01Stabilized liquid and lyophilized ADAMTS13 formulations
#15 | 2019-08-01 ✅ Patent 11,160,850 granted on 2021-11-02Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders
#16 | 2019-06-27 ✅ Patent 11,098,132 granted on 2021-08-24Anti-factor IX Padua antibodies
#17 | 2019-05-30 ✅ Patent 11,124,787 granted on 2021-09-21ADAMTS13-containing compositions having thrombolytic activity
#18 | 2019-05-16 ✅ Patent 10,900,979 granted on 2021-01-26Methods for testing effectiveness of a von Willebrand factor used in treating von Willebrand disease (VWD)
#19 | 2019-05-09 ✅ Patent 11,793,855 granted on 2023-10-24TFPI inhibitors and methods of use
#20 | 2019-04-18RECEPTACLE FOR ONE OR MORE SAMPLE CONTAINERS
#21 | 2019-03-14 ✅ Patent 10,655,099 granted on 2020-05-19Animal protein-free media for cultivation of cells
#22 | 2019-02-28 ✅ Patent 11,299,533 granted on 2022-04-12Purification of factor VIII subspecies
#23 | 2019-01-24METHOD FOR INCUBATING LIQUIDS
#24 | 2018-07-26 ✅ Patent 10,238,720 granted on 2019-03-26Stabilized liquid and lyophilized ADAMTS13 formulations
#25 | 2018-06-07 ✅ Patent 10,800,816 granted on 2020-10-13TFPI inhibitors and methods of use
#26 | 2018-04-26COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION
#27 | 2018-04-19METHOD FOR PICKING A COLONY OF CELLS
#28 | 2018-03-15 ✅ Patent 11,001,613 granted on 2021-05-11TFPI inhibitors and methods of use
#29 | 2018-03-01 ✅ Patent 10,208,106 granted on 2019-02-19Removal of serine proteases by treatment with finely divided silicon dioxide
#30 | 2018-02-22 ✅ Patent 10,221,400 granted on 2019-03-05Method of producing a polypeptide or virus of interest in a continuous cell culture
#31 | 2018-02-15 ✅ Patent 10,100,099 granted on 2018-10-16Method of producing recombinant high molecular weight vWF in cell culture
#32 | 2017-12-28 ✅ Patent 10,576,160 granted on 2020-03-03Nucleophilic catalysts for oxime linkage
#33 | 2017-12-21 ✅ Patent 10,696,731 granted on 2020-06-30Oligopeptide-free cell culture media
#34 | 2017-08-24 ✅ Patent 10,414,793 granted on 2019-09-17Nucleophilic catalysts for oxime linkage
#35 | 2017-08-17 ✅ Patent 10,189,888 granted on 2019-01-29Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
#36 | 2017-08-10 ✅ Patent 10,189,889 granted on 2019-01-29Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
#37 | 2017-08-10 ✅ Patent 10,413,600 granted on 2019-09-17Subcutaneous administration of ADAMTS13
#38 | 2017-06-22 ✅ Patent 9,873,720 granted on 2018-01-23TFPI inhibitors and methods of use
#39 | 2017-06-22 ✅ Patent 10,287,319 granted on 2019-05-14Biologically active peptides
#40 | 2017-06-08 ✅ Patent 10,201,586 granted on 2019-02-12TFPI inhibitors and methods of use
#41 | 2017-06-01 ✅ Patent 10,209,263 granted on 2019-02-19Methods of measuring adamts 13 activity
#42 | 2017-04-27 ✅ Patent 9,937,244 granted on 2018-04-10Stabilized liquid and lyophilized ADAMTS13 formulations
#43 | 2017-02-23 ✅ Patent 10,072,254 granted on 2018-09-11Cell culture methods for expressing ADAMTS13 protein
#44 | 2017-02-16 ✅ Patent 10,144,776 granted on 2018-12-04Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
#45 | 2017-02-09 ✅ Patent 10,124,033 granted on 2018-11-13Peptides and methods of use
#46 | 2017-01-12 ✅ Patent 9,834,591 granted on 2017-12-05Method of producing recombinant high molecular weight vWF in cell culture
#47 | 2016-12-15 ✅ Patent 10,350,301 granted on 2019-07-16Blood coagulation protein conjugates
#48 | 2016-11-10 ✅ Patent 10,527,551 granted on 2020-01-07Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use
#49 | 2016-08-25 ✅ Patent 10,125,189 granted on 2018-11-13Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
#50 | 2016-05-12 ✅ Patent 10,251,941 granted on 2019-04-09Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life
#51 | 2016-05-12 ✅ Patent 10,232,022 granted on 2019-03-19Lyophilized recombinant VWF formulations
#52 | 2016-02-18 ✅ Patent 10,036,002 granted on 2018-07-31Factor X activation
#53 | 2015-12-10 ✅ Patent 10,053,500 granted on 2018-08-21Variant of antihemophilic factor VIII having increased specific activity
#54 | 2015-08-20 ✅ Patent 9,834,593 granted on 2017-12-05IgG stimulated remyelination of peripheral nerves
#55 | 2015-05-14 ✅ Patent 9,889,248 granted on 2018-02-13Syringe storage tray
#56 | 2014-12-18 ✅ Patent 9,855,331 granted on 2018-01-02Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH
#57 | 2014-10-09 ✅ Patent 10,378,004 granted on 2019-08-13Protein purification by anion exchange chromatography
#58 | 2014-09-18 ✅ Patent 10,183,976 granted on 2019-01-22Method for producing factor H from a plasma precipitation fraction
#59 | 2014-09-18 ✅ Patent 9,896,501 granted on 2018-02-20Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs
#60 | 2014-09-04 ✅ Patent 9,958,456 granted on 2018-05-01OxMIF as a diagnostic marker
#61 | 2013-07-11 ✅ Patent 10,274,500 granted on 2019-04-30Characterization of subvisible particles using a particle analyzer
#62 | 2013-05-30 ✅ Patent 10,233,436 granted on 2019-03-19ADAMTS13-containing compositions having thrombolytic activity
#63 | 2012-05-03 ✅ Patent 10,202,416 granted on 2019-02-12Purification method for divalent cation binding proteins on anion exchange resin
#64 | 2010-03-25 ✅ Patent 10,301,376 granted on 2019-05-28Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
Also check out BAXALTA GMBH's (Zug, Switzerland) applicant profile with 34 patent applications submitted.
133129 ⎘